Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response Samuel A. BobholzAlisha HoefsPeter S. LaViolette Correction Open access 18 March 2024 Pages: 243 - 243
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database Ping ZhuPavel S. Pichardo-RojasYoshua Esquenazi Research 16 March 2024 Pages: 77 - 89
Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients Sachiv ChakravartiCathleen C. KuoDebraj Mukherjee Correction 15 March 2024 Pages: 487 - 487
Correction to: Prognostic factors analysis of diffuse midline glioma Jing JiangWen-bin LiShao-wen Xiao Correction Open access 15 March 2024 Pages: 293 - 293
Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study Vladimir N. KasatkinElizaveta N. RomanovaAlexander F. Karelin Research 15 March 2024 Pages: 57 - 67
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study Vincenzo Di NunnoGiuseppe LombardiEnrico Franceschi Research 08 March 2024 Pages: 145 - 154
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis Lucca B. PalavaniGuilherme Melo SilvaWellingson Paiva Review 08 March 2024 Pages: 373 - 385
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis Thomas GraillonBetty SalguesOlivier Chinot Research 07 March 2024 Pages: 427 - 436
Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma Kiyotaka YokogamiTakashi WatanabeHideo Takeshima Research Open access 06 March 2024 Pages: 455 - 465
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review Eric SinghMuhammet Enes GursesAshish H. Shah Correction 06 March 2024 Pages: 49 - 49
Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1 Brianna C. PeacockSanjna TripathyAnisha B. Patel Case Study 05 March 2024 Pages: 515 - 522
Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors Andrew B. BarbourBarbara BlouwJonathan T. Yang Case Study 05 March 2024 Pages: 509 - 514
Impact of trametinib on the neuropsychological profile of NF1 patients Eve LalancetteÉdith CantinSarah Lippé Research 05 March 2024 Pages: 447 - 454
Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly Mei LuoJiangfan YuRui Tang Research 05 March 2024 Pages: 415 - 425
Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review Jayne S. WilsonCaroline MainBarry Pizer Correction Open access 05 March 2024 Pages: 35 - 37
Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients Sachiv ChakravartiCathleen C. KuoDebraj Mukherjee Research 04 March 2024 Pages: 477 - 485
Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors Tao TongHan ChenLiyong Zhong Research 04 March 2024 Pages: 467 - 476
Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas Mark A. DavisonDaniel T. LillyLilyana Angelov Research Open access 04 March 2024 Pages: 437 - 446
Effect of sarcopenia and frailty on outcomes among patients with brain metastases Mervyn Jun Rui LimZheting ZhangTseng Tsai Yeo Case Study 02 March 2024 Pages: 169 - 180
Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers Kanji NakagawaKoji TakanoHideyuki Arita Research 02 March 2024 Pages: 397 - 406
Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review Yasuhito KegoyaYoshihiro OtaniIsao Date Case Study Open access 01 March 2024 Pages: 201 - 210
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors James L. RogersThomas WallMarta Penas-Prado Case Study Open access 01 March 2024 Pages: 349 - 359
CPLX2 is a novel tumor suppressor and improves the prognosis in glioma Yuanbing ChenJieling NingJun Huang Research 01 March 2024 Pages: 63 - 74
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study Meimei YuYing GeHuicong Shen Research 29 February 2024 Pages: 305 - 313
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery Santiago CepedaSergio García-GarcíaRosario Sarabia Research 28 February 2024 Pages: 387 - 396
Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis Millan R. KanayaJonathan GreenbergAna-Maria Vranceanu Research 27 February 2024 Pages: 315 - 322
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence Mohamed JallohSamuel Berchi Kankam Correspondence 23 February 2024 Pages: 365 - 367
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center Melek Tugce YilmazAlper KahveciogluFaruk Zorlu Research Open access 22 February 2024 Pages: 295 - 303
Prognostic factors analysis of diffuse midline glioma Jing JiangWen-bin LiShao-wen Xiao Research Open access 21 February 2024 Pages: 285 - 292
Validation of a methylation-based signature for subventricular zone involvement in glioblastoma Felix EhretOliver ZühlkeDavid Kaul Research Open access 20 February 2024 Pages: 89 - 97
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab Pushan DasguptaAlexander OuNazanin K. Majd Case Study 19 February 2024 Pages: 181 - 188
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma Phioanh Leia NghiemphuJeremie VitteMarco Giovannini Case Study Open access 19 February 2024 Pages: 339 - 348
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes Thais Baccili Cury MegidZeynep BaskurtElena Elimova Research Open access 19 February 2024 Pages: 111 - 122
Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response Samuel A. BobholzAlisha HoefsPeter S. LaViolette Research Open access 19 February 2024 Pages: 233 - 241
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery Motoyuki UmekawaYuki ShinyaNobuhito Saito Research Open access 18 February 2024 Pages: 51 - 61
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma Jason P. SheehanGeorgios MantziarisAdomas Bunevicius Correspondence 16 February 2024 Pages: 231 - 232
Stereotactic radiosurgery for intracranial adenoid cystic carcinoma Jason P. SheehanRaj SinghDaniel M. Trifiletti Correspondence 16 February 2024 Pages: 229 - 230
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors Lisa M. ArnoldYoji HoshinaJoe Mendez Case Study 16 February 2024 Pages: 211 - 217
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma Yukina ShiraiToshihide UenoShinji Kohsaka Research Open access 16 February 2024 Pages: 75 - 88
Correction to: CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization Manali RanadeSridhar EpariTejpal Gupta Correction 15 February 2024 Pages: 199 - 199
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection David WasilewskiJulia OnkenPhilip Bischoff Research Open access 15 February 2024 Pages: 155 - 167
The role of spine stereotactic radiosurgery for patients with breast cancer metastases Suchet TaoriSamuel AdidaPeter C. Gerszten Research 14 February 2024 Pages: 257 - 266
Comment: Additional factors affecting cognitive function in low grade glioma patients Polina AngelovaMaria Gicheva Correspondence 13 February 2024 Pages: 361 - 362
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype Antonio DonoJose TorresYoshua Esquenazi Research 13 February 2024 Pages: 99 - 109
Repeated surgical resections for management of high-grade glioma and its impact on quality of life Jun Min KoayLoizos MichaelidesDavid S. Sabsevitz Research 13 February 2024 Pages: 267 - 273
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review Gina WatanabeJennifer Manyu WongPaolo Palmisciano Review 12 February 2024 Pages: 379 - 394
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery Andrew FairchildJoseph K. SalamaScott R. Floyd Case Study 10 February 2024 Pages: 219 - 227
The importance of considering competing risks in recurrence analysis of intracranial meningioma Christian MirianLasse Rehné JensenTiit Mathiesen Research Open access 10 February 2024 Pages: 503 - 511
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis Obada T. AlhalabiPhilip Dao TrongChristine Jungk Research Open access 09 February 2024 Pages: 245 - 255